Ognomy, the Sleep Telemedicine platform that is transitioning sleep apnea care from the clinic to the home, continues to expand its services with the announcement of its newly appointed Chief Operating Officer, Ken Rosenfeld.
Buffalo, NY, March 8th – Mr. Rosenfeld brings two decades of experience to Ognomy, with deep expertise in spearheading disruptive digital health innovation and leading high performing teams to deliver transformational growth.
Before joining Ognomy as its Chief Operating Officer, Ken was the COO of Casana who are building a revolutionary clinical monitoring tool built into a toilet seat. He led business operations and regulatory affairs, having joined the PhD founder in mid 2019 as the first employee of the company, before helping the company scale to 35 people, two offices, and over $16M of venture capital funding.
Prior to Casana, Ken held the role of CEO and President of eHealth Technologies, which he co-founded in 2006. eHealth provides digital health record aggregation and image exchange services. Ken led dramatic innovation and growth at the company, and brought in significant venture funding, ultimately realizing 65% 10-year revenue CAGR. While at eHealth Technologies, Ken received the Rochester-area “Business Person of the Year” honor in 2015. Previously, Ken ran worldwide organizations for Kodak’s Health Group, which acquired the Cemax-Icon business where Ken started his entrepreneurial medical imaging efforts in the San Francisco Bay Area.
Ken is a graduate of the University of Pennsylvania having received a Bachelor of Science degree in Bioengineering with a minor in Computer Science. Ken is also a member of the Upstate Venture Connect UNY50 Leadership Network working to provide a more connected startup ecosystem in Upstate NY.
Ognomy is the vision of founder and CEO Daniel Rifkin, MD, a New York-based sleep medicine specialist who commented on the appointment earlier today,
“We are thrilled to have Ken join the team – his expertise and strategic vision will be invaluable at this time as we expand our offering across the US. It is an incredible opportunity to support patients, spark business growth and continue to innovate the platform while we create a flexible work schedule that benefits everyone in the sleep space.”
Ognomy continues to scale across the US, with its leadership team clearly keeping pace.
The startup, which was a finalist in Global Wellness Institute’s Innovation Awards, is the only end-to-end virtual platform where sleep specialists can evaluate, diagnose, and treat patients all from the comfort of their homes. It is a potentially lifesaving tool for the estimated 25 million Americans suffering from the pervasive sleep disorder. And for sleep physicians and treatment providers exploring business growth opportunities, Ognomy allows them to directly connect in a virtual marketplace to order home sleep testing and treatment devices, or to take their own practice fully online using the patented Ognomy technology.
About sleep apnea
Known as the “not-so-silent killer” due to its association with loud snoring, obstructive sleep apnea occurs when the muscles in the throat relax and close during sleep, which disrupts breathing. As a result, the body subconsciously wakes itself in an attempt to return breathing to normal. For many who suffer from sleep apnea, this pattern can be repeated hundreds of times in a single night. Left untreated, the sleep disorder can lead to a wide range of health complications, including increased risk of heart attack, high blood pressure, type 2 diabetes, liver problems, and accidents due to drowsiness or lack of concentration.
Contact for press enquiries: Judy.email@example.com
Ognomy patient registration: patient.ognomy.com